Typhoid Antibody Testing Market Size

  • Report ID: 4164
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Typhoid Antibody Testing Market Size

Typhoid Antibody Testing Market size was valued at USD 1.08 Billion in 2023 and is expected to cross USD 2.75 Billion by the end of 2036, registering more than 7.5% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of typhoid antibody testing is estimated at USD 1.15 Billion. The market is estimated to grow on the back of a rapid increase in typhoid cases globally as an instance of poor sanitation practices. According to the report by the World Health Organization (WHO), by 2030, 1.6 billion people around the world are estimated to lack proper safe drinking water and 2.8 billion people are expected to be not able to attain safe sanitation services. Also in Asia Pacific, more than 4 million cases are diagnosed with typhoid every year due to improper sanitation practices.  

The global typhoid antibody testing market is also estimated to witness growth owing to the rising government efforts to make people aware of typhoid, develop nursing facilities, and manage the number of cases in their respective regions.


Typhoid Antibody Testing Market
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4164
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of typhoid antibody testing is estimated at USD 1.15 Billion.

The typhoid antibody testing market size was valued at USD 1.08 Billion in 2023 and is expected to cross USD 2.75 Billion by the end of 2036, registering more than 7.5% CAGR during the forecast period i.e., between 2024-2036. Typhoid is on the rise in developing countries and increased competition among top competitors to produce fast and cost-effective diagnostic kits to diagnose typhoid cases is anticipated to boost the market growth.

Asia Pacific is set to hold the highest revenue share of 41% by 2036, driven by increase in typhoid cases in the region.

IDL Biotech AB, LINEAR CHEMICALS, S.L.U, Medical Innovation Ventures Sdn Bhd, Thermo Fisher Scientific, Nectar Lifesciences Ltd., DIALAB GmbH., BIOSYSTEMS S.A., Siemens Healthcare GmbH, NanoEnTek, CerTest Biotec S.L.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying